Esophagus Cancer Tissue Array, Including TNM And Pathology Grade, 26 Cases/78 Cores, Replacing BC02111|ヒト組織アレイ

掲載日情報:2015/08/07 現在Webページ番号:173139

US Biomax社は、豊富なラインナップの組織アレイ、組織切片(凍結、FFPE)を提供しているメーカーです。
US Biomax社のヒト組織アレイ(Esophagus Cancer Tissue Array, Including TNM And Pathology Grade, 26 Cases/78 Cores, Replacing BC02111)をご紹介します。

ヒト組織アレイは、ドナーからインフォームドコンセントを取得した組織を使用しています。
ドナーの組織は、HIV、Hepatitis B、Hepatitis Cが陰性であることを確認しています。
本製品は研究用です。研究用以外には使用できません。

ヒト組織アレイの価格

[在庫・価格 :2025年04月29日 20時35分現在]

※ 表示されている納期は弊社に在庫が無く、取り寄せた場合の納期目安となります。
詳細 商品名
  • 商品コード
  • メーカー
  • 包装
  • 価格
  • 在庫
  • 法規制等
納期 文献数
Human Esophagus cancer tissue array, replacing BC02111
2~3週間 ※ 表示されている納期は弊社に在庫がなく、取り寄せた場合の目安納期となります。 0

[在庫・価格 :2025年04月29日 20時35分現在]

※ 表示されている納期は弊社に在庫が無く、取り寄せた場合の納期目安となります。

Human Esophagus cancer tissue array, replacing BC02111

文献数: 0

目次に戻る

ヒト組織アレイの特長

Microarray Panel: Esophagus carcinoma microarray, containing 13 cases of adenocarcinoma, with 13 matched or unmatched adjacent normal tissue, triplicate cores per case
Cores: 78
組織アレイ
Cases: 26
Layout: 10 cols × 8 rows
Core Diameter: 1.5 mm
Thickness: 5 µm
Quality Control: Anti-Actin confirmed
Applications:

Routine histology procedures including ImmunoHistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found on our support page.

Notes: Unless specified, all TMA slides are not coated with extra layer of paraffin (tissue cores can be easily seen on the glass), so there is no need to bake, can be directly put into xylene for de-paraffin procedure.

*Tissue Microarray Slide Types:

  • Unstained: unstained paraffin tissue microarray slide.
  • Trial: tissue microarray trial slide. 10% - 25% of cores missing. Good for titrating antibody dilution and experiment conditions. Limited numbers are available, to 2 per item per order. Test slides (tissue arrays with catalog numbers ending with 241 or 242) are recommended as a substitute.
  • H and E: Hematoxylin and Eosin stained tissue array slide.

目次に戻る

ヒト組織アレイの仕様表

Pos No. Sex Age Organ Pathology diagnosis Grade Stage TNM Type †
A1 1 M 71 Esophagus Adenocarcinoma 1 III T4N0M0 Malignant
A2 2 M 71 Esophagus Adenocarcinoma 1 III T4N0M0 Malignant
A3 3 M 71 Esophagus Adenocarcinoma 1 III T4N0M0 Malignant
A4 4 M 70 Esophagus Adenocarcinoma 1 IIa T2N0M0 Malignant
A5 5 M 70 Esophagus Adenocarcinoma 1 IIa T2N0M0 Malignant
A6 6 M 70 Esophagus Adenocarcinoma 1 IIa T2N0M0 Malignant
A7 7 M 64 Esophagus Mucinous adenocarcinoma 2 IIa T3N0M0 Malignant
A8 8 M 64 Esophagus Mucinous adenocarcinoma 2 IIa T3N0M0 Malignant
A9 9 M 64 Esophagus Mucinous adenocarcinoma 2 IIa T3N0M0 Malignant
A10 10 M 62 Esophagus Adenocarcinoma 3 IIb T2N1M0 Malignant
B1 11 M 62 Esophagus Adenocarcinoma 3 IIb T2N1M0 Malignant
B2 12 M 62 Esophagus Adenocarcinoma 2 IIb T2N1M0 Malignant
B3 13 M 58 Esophagus Adenocarcinoma 2 III T4N0M0 Malignant
B4 14 M 58 Esophagus Adenocarcinoma 2 III T4N0M0 Malignant
B5 15 M 58 Esophagus Adenocarcinoma 2 III T4N0M0 Malignant
B6 16 M 56 Esophagus Adenocarcinoma 3 III T3N1M0 Malignant
B7 17 M 56 Esophagus Adenocarcinoma 3 III T3N1M0 Malignant
B8 18 M 56 Esophagus Adenocarcinoma 3 III T3N1M0 Malignant
B9 19 F 33 Esophagus Adenocarcinoma (chronic inflammation of smooth muscle and blood vessel) IIa T3N0M0 Malignant
B10 20 F 33 Esophagus Adenocarcinoma (chronic inflammation of smooth muscle and blood vessel) IIa T3N0M0 Malignant
C1 21 F 33 Esophagus Adenocarcinoma (chronic inflammation of smooth muscle and blood vessel) IIa T3N0M0 Malignant
C2 22 M 53 Esophagus Adenocarcinoma 3 IIa T3N0M0 Malignant
C3 23 M 53 Esophagus Adenocarcinoma 3 IIa T3N0M0 Malignant
C4 24 M 53 Esophagus Adenocarcinoma 3 IIa T3N0M0 Malignant
C5 25 F 67 Esophagus Adenocarcinoma 3 III T4N0M0 Malignant
C6 26 F 67 Esophagus Adenocarcinoma 3 III T4N0M0 Malignant
C7 27 F 67 Esophagus Adenocarcinoma 3 III T4N0M0 Malignant
C8 28 M 63 Esophagus Adenocarcinoma 3 IIa T3N0M0 Malignant
C9 29 M 63 Esophagus Adenocarcinoma 3 IIa T3N0M0 Malignant
C10 30 M 63 Esophagus Adenocarcinoma 3 IIa T3N0M0 Malignant
D1 31 M 48 Esophagus Adenocarcinoma 3 IIa T2N0M0 Malignant
D2 32 M 48 Esophagus Adenocarcinoma 3 IIa T2N0M0 Malignant
D3 33 M 48 Esophagus Adenocarcinoma 3 IIa T2N0M0 Malignant
D4 34 M 56 Esophagus Mucinous adenocarcinoma 1 IIa T3N0M0 Malignant
D5 35 M 56 Esophagus Mucinous adenocarcinoma 3 IIa T3N0M0 Malignant
D6 36 M 56 Esophagus Mucinous adenocarcinoma 1 IIa T3N0M0 Malignant
D7 37 M 65 Esophagus Adenocarcinoma 3 IIa T3N0M0 Malignant
D8 38 M 65 Esophagus Adenocarcinoma 3 IIa T3N0M0 Malignant
D9 39 M 65 Esophagus Adenocarcinoma 3 IIa T3N0M0 Malignant
D10 40 Blank
E1 41 M 56 Esophagus Cancer adjacent normal esophagus tissue Malignant
E2 42 M 56 Esophagus Cancer adjacent normal esophagus tissue (smooth muscle and gland tissue) Malignant
E3 43 M 56 Esophagus Cancer adjacent normal esophagus tissue Malignant
E4 44 M 70 Esophagus Cancer adjacent normal esophagus tissue of No.4 Malignant
E5 45 M 70 Esophagus Cancer adjacent normal esophagus tissue of No.4 Malignant
E6 46 M 70 Esophagus Cancer adjacent normal esophagus tissue of No.4 Malignant
E7 47 M 64 Esophagus Cancer adjacent normal esophagus tissue of No.7 Malignant
E8 48 M 64 Esophagus Cancer adjacent normal esophagus tissue of No.7 Malignant
E9 49 M 64 Esophagus Cancer adjacent normal esophagus tissue (smooth muscle, blood vessel and gland tissue) of No.7 Malignant
E10 50 M 62 Esophagus Cancer adjacent normal esophagus tissue of No.10 Malignant
F1 51 M 62 Esophagus Cancer adjacent normal esophagus tissue of No.10 Malignant
F2 52 M 62 Esophagus Cancer adjacent normal esophagus tissue of No.10 Malignant
F3 53 F 63 Esophagus Cancer adjacent normal esophagus tissue Malignant
F4 54 F 63 Esophagus Cancer adjacent normal esophagus tissue Malignant
F5 55 F 63 Esophagus Cancer adjacent normal esophagus tissue Malignant
F6 56 M 56 Esophagus Cancer adjacent normal esophagus tissue of No.16 Malignant
F7 57 M 56 Esophagus Cancer adjacent normal esophagus tissue of No.16 Malignant
F8 58 M 56 Esophagus Cancer adjacent normal esophagus tissue of No.16 Malignant
F9 59 F 33 Esophagus Cancer adjacent normal esophagus tissue of No.19 Malignant
F10 60 F 33 Esophagus Cancer adjacent normal esophagus tissue of No.19 Malignant
G1 61 F 33 Esophagus Cancer adjacent normal esophagus tissue of No.19 Malignant
G2 62 M 53 Esophagus Cancer adjacent normal esophagus tissue of No.22 Malignant
G3 63 M 53 Esophagus Cancer adjacent normal esophagus tissue of No.22 Malignant
G4 64 M 53 Esophagus Cancer adjacent normal esophagus tissue of No.22 Malignant
G5 65 F 67 Esophagus Cancer adjacent normal esophagus tissue of No.25 Malignant
G6 66 F 67 Esophagus Cancer adjacent normal esophagus tissue of No.25 Malignant
G7 67 F 67 Esophagus Cancer adjacent normal esophagus tissue of No.25 Malignant
G8 68 M 63 Esophagus Cancer adjacent normal esophagus tissue of No.28 Malignant
G9 69 M 63 Esophagus Cancer adjacent normal esophagus tissue of No.28 Malignant
G10 70 M 63 Esophagus Cancer adjacent normal esophagus tissue of No.28 Malignant
H1 71 M 48 Esophagus Cancer adjacent normal esophagus tissue of No.31 Malignant
H2 72 M 48 Esophagus Cancer adjacent normal esophagus tissue of No.31 Malignant
H3 73 M 48 Esophagus Cancer adjacent normal esophagus tissue of No.31 Malignant
H4 74 M 56 Esophagus Cancer adjacent normal esophagus tissue of No.34 Malignant
H5 75 M 56 Esophagus Cancer adjacent normal esophagus tissue (smooth muscle, blood vessel and gland tissue) of No.34 Malignant
H6 76 M 56 Esophagus Cancer adjacent normal esophagus tissue of No.34 Malignant
H7 77 M 48 Esophagus Cancer adjacent normal esophagus tissue (chronic inflammation of smooth muscle and blood vessel) Malignant
H8 78 M 48 Esophagus Cancer adjacent normal esophagus tissue Malignant
H9 79 M 48 Esophagus Cancer adjacent normal esophagus tissue Malignant
H10 80 Blank
M 58 Skin Malignant melanoma (tissue marker) Malignant

*For precise diagnosis, refer to pathology description.

目次に戻る

ヒト組織アレイのFAQ

目次に戻る

お問い合わせ先

(テクニカルサポート 試薬担当)

reagent@funakoshi.co.jp

製品情報は掲載時点のものですが、価格表内の価格については随時最新のものに更新されます。お問い合わせいただくタイミングにより製品情報・価格などは変更されている場合があります。
表示価格に、消費税等は含まれていません。一部価格が予告なく変更される場合がありますので、あらかじめご了承下さい。